Enhancement of Bone Regeneration and Healing in the Extremities by the Use of Autologous BonoFill-II

ConditionBone Fracture
Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age18-80
SponsorBonusBio Group Ltd

About this trial

The purpose of this clinical study is to evaluate the safety and the efficacy of BonoFill-II as an autologous bone-regenerating graft in the reconstruction of deficient bone in two clinical indications:

1. Long and short bone extra-articular comminuted fracture 2. Long and short bones extra and intra articular defect /Gap or non-union, incapable of self-regeneration

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Long and short bones extra articular comminuted fracture or

Long and short bones extra and intra articular defect/gap or non union, incapable of self-regeneration

Disqualifiers

Age is under 18 or above 80

A simple fracture manageable by one definitive treatment

Pregnant or lactating women

Patients with active infection that is in question and needs osteogenic treatment.

Trial design

Design model

Single group

Treatments tested in this trial

  • BonoFill-II

    Biological/Vaccine

    Surgery will be performed under local or general anesthetics according to the Investigator's and anesthesiologist discretion. A standard orthopedic approach will be made according to the fracture site.Then the transplantation of BonoFill-II into the fracture site and the fixation of the fracture by intramedullary nail or plate and screws or external fixator as required will be performed. internal fixation (plate and screws and intramedullary nails) will not be routinely removed. External fixators will be removed upon achievement of satisfactory bone union.

Treatment groups

40 Participants
are divided into 1 treatment group
Group A: Intervention ArmExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Primary safety endpoint: Absence of treatment-emergent appearance of safety issues

Subjects demonstrating no appearance of heterotrophic bone ossification, excessive bone formation and/or any abnormalities in the treated site, in the proximal or distal joint by visual examination of the transplantation site and by X-ray and/or CT.

Time frame
Throughout the post-intervention 12-month follow-up
2

Efficacy endpoint: Bone continuity

Bone union, as assessed by X-ray and CT. CT scans are performed 6 and 12 months post operation, to verify bone regeneration and complete bone continuity was achieved.

Time frame
Starting 4-week follow-up and through to the end of the 12-month follow-up
3

Functional efficacy endpoint: Weight bearing ability

clinical examination of weight bearing ability for lower extremities or coffee-cup weight bearing ability for upper extremities. The physician assesses the functionality of the operated limb, by testing the patients ability to bear their weight when standing (in case of lower limb bone defect) or by coffee cup holding simulation (in case of upper limb bone defect).

Time frame
The test is performed at 3, 6 and 12 months post operation.

Secondary outcomes

Other outcomes

1

Lack of pain at the surgical site

Pain at the surgical site will be evaluated using a VAS pain scale, this assessment will be used in cases of bone defect where weight-bearing is not applicable due to further limb injuries (such as nerve injuries or other non-bone defects).

Time frame
3, 6 and 12 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.